Milestone
Sep 2025
ART - 002 / 003
CM
Oct 8, 2025
Designed and intiated studies on two new genetic treatments with our proprietary technology, ”SOT Caller” These treatments are estimated to each reach 300-700m in AR once approved.
Designed and intiated studies on two new genetic treatments with our proprietary technology, ”SOT Caller” These treatments are estimated to each reach 300-700m in AR once approved.